Clinical trial
Investigation of the Effects of Anticoagulant/Antiaggregant Use on Postoperative Bleeding Risk in Patients Operated for Bladder Tumor and Benign Prostatic Hyperplasia
NCT05314582 is registered in ClinicalTrials.gov with Bezmialem Vakif University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Effects of Anticoagulant/Antiaggregant Use on Postoperative Bleeding Risk in Patients Operated for Bladder Tumor and Benign Prostatic Hyperplasia
- Lead sponsor
- Bezmialem Vakif University
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 10, 2022
- Completion date
- January 10, 2023
- Enrollment
- 500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood transfusion complication, hematuria, operative bleeding, retention, urinary